Check Out What Whales Are Doing With MRNA
Portfolio Pulse from Benzinga Insights
A whale investor has taken a bullish stance on Moderna (NASDAQ:MRNA), with 50% of investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $65.0 to $120.0 for Moderna over the last 3 months. Argus Research has maintained their Buy rating on Moderna, with a price target of $140.
September 28, 2023 | 4:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
A whale investor has shown bullish sentiment towards Moderna, with a targeted price range of $65-$120. Argus Research maintains a Buy rating with a price target of $140.
The bullish sentiment from a whale investor, along with the maintained Buy rating from Argus Research, indicates a positive outlook for Moderna. This could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100